Lercanidipine hydrochloride
Nitrates, calcium-channel blockers & other antianginal drugs | Cardiovascular System
Items (National)
4.2M
NHS Cost
£15.3M
Practices
6,786
Avg per Practice
618
Overview
Lercanidipine hydrochloride is prescribed by 6,786 GP practices across England. In the last 12 months, 4,191,803 items were prescribed at a total cost of £15,335,974 to the NHS. It is classified under BNF Chapter Cardiovascular System, Section Nitrates, calcium-channel blockers & other antianginal drugs.
Monthly Prescribing Trend
Jun 2026
340,211
Jun 2026
318,792
Jun 2026
351,161
Jun 2026
342,717
Jun 2026
334,310
Jun 2026
356,715
Jun 2026
344,095
Jun 2026
358,596
Jun 2026
366,033
Jun 2026
331,771
Jun 2026
359,509
Jun 2026
366,548
Prescribing by Area
| Area | Items | Practices | Avg/Practice | vs National |
|---|---|---|---|---|
| NE | 217.6K | 140 | 1,554 | +151.6% ▲ |
| NR | 196.0K | 75 | 2,613 | +323.0% ▲ |
| WF | 115.8K | 62 | 1,868 | +202.4% ▲ |
| CO | 112.1K | 44 | 2,548 | +312.6% ▲ |
| YO | 107.9K | 49 | 2,202 | +256.5% ▲ |
| PO | 103.5K | 62 | 1,670 | +170.3% ▲ |
| NG | 102.6K | 138 | 744 | +20.4% ▲ |
| PE | 99.1K | 92 | 1,077 | +74.4% ▲ |
| EX | 98.3K | 62 | 1,586 | +156.8% ▲ |
| DN | 93.8K | 87 | 1,078 | +74.6% ▲ |
| IP | 91.5K | 62 | 1,476 | +139.0% ▲ |
| M | 85.2K | 175 | 487 | -21.1% ▼ |
| LS | 85.1K | 91 | 935 | +51.4% ▲ |
| DL | 83.8K | 43 | 1,948 | +215.4% ▲ |
| S | 80.4K | 160 | 503 | -18.6% ▼ |
| ST | 75.0K | 84 | 893 | +44.5% ▲ |
| B | 74.2K | 255 | 291 | -52.9% ▼ |
| GU | 72.9K | 67 | 1,088 | +76.1% ▲ |
| FY | 71.1K | 31 | 2,293 | +271.3% ▲ |
| RG | 70.8K | 67 | 1,057 | +71.1% ▲ |
Top Prescribing Practices
| Practice | Items |
|---|---|
| HEALTH CARE FIRST PARTNERSHIP | 16,539 |
| VALENS MEDICAL PARTNERSHIP | 15,383 |
| HAXBY GROUP PRACTICE | 10,975 |
BNF Classification
- Chapter: Cardiovascular System
- Section: Nitrates, calcium-channel blockers & other antianginal drugs
- Paragraph: Calcium-channel blockers
Related drugs in this section
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.